Pay in 4 interest-free payments of $5.67 Learn more
Ships within 48 hours · Estimated delivery Sep 2 - Sep 7
Novo Nordisk prescribing information states that "similar exposure" is achieved across all three approved injection sites
Binding of GLP-1 or GLP-1RAs to these receptors can activate the cAMP/PKA signaling pathway, affecting key transcription factors like NF-B
These adverse effects are primarily related to the pharmacological action of tirzepatide on GLP-1 and GIP receptors in the gut and central nervous system, rather than the anatomical location of injection
DOI: 10.1056/NEJMoa1603827
The tablet format provides precise, consistent dosing without the need for measuring or special storage requirements, making it easy to maintain regular supplementation schedules
Do not take two doses close together to make up for a missed one
